Uncovering patterns of inhaler technique and reliever use: the value of objective, personalized data from a digital inhaler.

IF 3.1 3区医学 Q1 PRIMARY HEALTH CARE

NPJ Primary Care Respiratory Medicine Pub Date : 2024-08-20 DOI:10.1038/s41533-024-00382-x

Mark L Levy, Janwillem W H Kocks, Sinthia Bosnic-Anticevich, Guilherme Safioti, Michael Reich, Michael Depietro, Mario Castro, Nabeel Farooqui, Njira L Lugogo, Randall Brown, Tanisha Hill, Thomas Li, Henry Chrystyn

{"title":"Uncovering patterns of inhaler technique and reliever use: the value of objective, personalized data from a digital inhaler.","authors":"Mark L Levy, Janwillem W H Kocks, Sinthia Bosnic-Anticevich, Guilherme Safioti, Michael Reich, Michael Depietro, Mario Castro, Nabeel Farooqui, Njira L Lugogo, Randall Brown, Tanisha Hill, Thomas Li, Henry Chrystyn","doi":"10.1038/s41533-024-00382-x","DOIUrl":null,"url":null,"abstract":"Electronic inhalers provide information about patterns of routine inhaler use. During a 12-week study, 360 asthma patients using albuterol Digihaler generated 53,083 inhaler events that were retrospectively analyzed. A total of 41,528 (78%) of the recorded inhalation events were suitable for flow analysis (having a PIF ≥ 18 L/min and <120 L/min). Median PIF, inhalation volume, inhalation duration, and time to PIF for these events steadily decreased between the first and last 10 days of the study, by 5.1%, 12.6%, 15.9%, and 6.4%, respectively. Continuous short-acting beta2-agonist (SABA) overuse, defined as ≥2 SABA inhalations/week throughout the study period, was seen in 29% (n = 104) of patients. Of 260 patients with ≥1 instance of acute short-term SABA overuse, 55 (21%) had a confirmed exacerbation. Electronic recording of real-life inhaler use can capture valuable, objective information that could inform disease management and clinical decision-making.","PeriodicalId":19470,"journal":{"name":"NPJ Primary Care Respiratory Medicine","volume":"34 1","pages":"23"},"PeriodicalIF":3.1000,"publicationDate":"2024-08-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11336086/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"NPJ Primary Care Respiratory Medicine","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1038/s41533-024-00382-x","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"PRIMARY HEALTH CARE","Score":null,"Total":0}

引用次数: 0

Abstract

Electronic inhalers provide information about patterns of routine inhaler use. During a 12-week study, 360 asthma patients using albuterol Digihaler generated 53,083 inhaler events that were retrospectively analyzed. A total of 41,528 (78%) of the recorded inhalation events were suitable for flow analysis (having a PIF ≥ 18 L/min and <120 L/min). Median PIF, inhalation volume, inhalation duration, and time to PIF for these events steadily decreased between the first and last 10 days of the study, by 5.1%, 12.6%, 15.9%, and 6.4%, respectively. Continuous short-acting beta₂-agonist (SABA) overuse, defined as ≥2 SABA inhalations/week throughout the study period, was seen in 29% (n = 104) of patients. Of 260 patients with ≥1 instance of acute short-term SABA overuse, 55 (21%) had a confirmed exacerbation. Electronic recording of real-life inhaler use can capture valuable, objective information that could inform disease management and clinical decision-making.

Abstract Image

查看原文本刊更多论文

揭示吸入器技术和缓解剂使用模式：数字吸入器提供的客观、个性化数据的价值。

电子吸入器可提供有关常规吸入器使用模式的信息。在一项为期 12 周的研究中，360 名使用阿布特罗-迪吉哈勒的哮喘患者产生了 53083 次吸入器事件，并对这些事件进行了回顾性分析。在记录的吸入事件中，共有 41528 次（78%）适合进行流量分析（PIF ≥ 18 L/min，29% 的患者（n = 104）过度使用 2-激动剂（SABA），即在整个研究期间 SABA 吸入次数≥2 次/周。在 260 例急性短期 SABA 过度使用≥1 次的患者中，55 例（21%）确诊为病情加重。电子记录现实生活中吸入器的使用情况可以获取宝贵的客观信息，为疾病管理和临床决策提供依据。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

NPJ Primary Care Respiratory Medicine PRIMARY HEALTH CARE-RESPIRATORY SYSTEM

CiteScore

5.50

自引率

6.50%

发文量

审稿时长

10 weeks

期刊介绍： npj Primary Care Respiratory Medicine is an open access, online-only, multidisciplinary journal dedicated to publishing high-quality research in all areas of the primary care management of respiratory and respiratory-related allergic diseases. Papers published by the journal represent important advances of significance to specialists within the fields of primary care and respiratory medicine. We are particularly interested in receiving papers in relation to the following aspects of respiratory medicine, respiratory-related allergic diseases and tobacco control: epidemiology prevention clinical care service delivery and organisation of healthcare (including implementation science) global health.